Tag: St Jude Medical

Battery performance alert and cybersecurity firmware updates for certain Abbott implantable...

The US FDA has approved a firmware update that is now available and is intended as a corrective action (recall), to reduce the risk...

New FDA approvals for Abbott’s MRI-ready devices

Abbott has announced the US Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labelling for the Quadra Assura MP cardiac resynchronisation therapy...

FDA updates Class I recall of St. Jude Medical’s ICDs and...

  In October 2016, St. Jude Medical recalled a subset of implantable cardioverter defibrillators (ICDs) and cardiac resynchronisation therapy defibrillators (CRT-Ds) due to reports of...

First Texas centre uses St Jude Medical Amplatzer Amulet

The Texas Cardiac Arrhythmia Institute at St David's Medical Center,  Austin, USA became the first facility in the US state of Texas to implant...

Educational Supplement ‒ St. Jude Medical: Tackling heart failure with innovative...

This educational supplement is only available in countries outside the USA. This educational supplement contains highlights of the 5th edition of The Future of Heart...

St Jude Medical announces Merlin cybersecurity updates

St Jude Medical has announced that it will immediately deploy the latest release of cyber security updates for its Merlin remote monitoring system, used...

Abbott completes the acquisition of St Jude Medical

Abbott has now completed the acquisition of St Jude Medical. The Abbott press release announcing the completion of the acquisition said, “The transaction provides...

US FDA clears St Jude Medical’s EnSite Precision cardiac mapping system

St Jude Medical has announced the US Food and Drug Administration (FDA) clearance of its EnSite Precision cardiac mapping system and Advisor FL circular...

AHA 2016: HeartMate 3 LVAS improves clinical outcomes compared with HeartMate...

A prespecified primary analysis of the MOMENTUM 3 US IDE clinical study has indicated improvement in clinical outcomes for advanced heart failure patients implanted...

Quadra Allure MP CRT-P gets CE mark approval for MRI labeling

St Jude Medical has announced CE mark approval for magnetic resonance (MR) conditional labeling for the company’s Quadra Allure MP cardiac resynchronisation therapy pacemaker (CRT-P). The...

Amulet study shows high implant success rates with Amplatzer Amulet LAA...

A study presented at the last late-breaking trial session of the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October-2 November, Washington, DC, USA) indicates...

Short episodes of atrial fibrillation may not increase risk of stroke

People with pacemakers or defibrillators who experience only short episodes of atrial fibrillation have a very low risk of stroke, suggesting that anticoagulants in...

St Jude Medical launches trial of Amplatzer Amulet left atrial appendage...

The St Jude Medical Amplatzer Amulet Investigational Device Exemption (IDE) trial, which will evaluate the safety and effectiveness of the company’s Amplatzer Amulet left...